UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Discovery of potent, orally active benzimidazole glucagon receptor antagonists

Bioorganic & medicinal chemistry, 2008-07, Vol.18 (13), p.3701-3705

2008

Volltextzugriff (PDF)

Discovery of a Novel Glucagon Receptor Antagonist N-[(4-{(1S)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes

Journal of medicinal chemistry, 2012-07, Vol.55 (13), p.6137-6148

2012

Volltextzugriff (PDF)

Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3832-3836

2000

Volltextzugriff (PDF)

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

Bioorganic & medicinal chemistry letters, 2011-01, Vol.21 (1), p.76-81

2011

Volltextzugriff (PDF)

Potent, selective human β3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (13), p.1869-1874

1999

Volltextzugriff (PDF)

Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression

Endocrinology (Philadelphia), 1998-12, Vol.139 (12), p.4920-4927

1998

Volltextzugriff (PDF)

Human β3-Adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (18), p.2111-2114

2000

Volltextzugriff (PDF)

Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo

European journal of pharmacology, 2007-01, Vol.555 (1), p.8-16

2007

Volltextzugriff (PDF)

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents

Bioorganic & medicinal chemistry letters, 2000-07, Vol.10 (13), p.1431-1434

2000

Volltextzugriff (PDF)

Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2000-10, Vol.10 (20), p.2283-2286

2000

Volltextzugriff (PDF)

Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonist

Bioorganic & medicinal chemistry letters, 1998-05, Vol.8 (9), p.1107-1112

1998

Volltextzugriff (PDF)

Human β3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties

Bioorganic & medicinal chemistry letters, 2001-02, Vol.11 (3), p.379-382

2001

Volltextzugriff (PDF)

Human β 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (18), p.2111-2114

2000

Volltextzugriff (PDF)

Molecular approaches to the discovery of new treatments for obesity

Current opinion in chemical biology, 1997-08, Vol.1 (2), p.204-209

1997

Volltextzugriff (PDF)

3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 1998-08, Vol.8 (16), p.2111-2116

1998

Volltextzugriff (PDF)

Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptor

Bioorganic & medicinal chemistry letters, 1998-05, Vol.8 (9), p.1101-1106

1998

Volltextzugriff (PDF)

Mutational analysis of beta-adrenergic receptor glycosylation

The Journal of biological chemistry, 1990-06, Vol.265 (18), p.10759-10764

1990

Volltextzugriff (PDF)

L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability

Bioorganic & medicinal chemistry letters, 1999-05, Vol.9 (9), p.1251-1254

1999

Volltextzugriff (PDF)

Human β3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

Bioorganic & medicinal chemistry letters, 1999-03, Vol.9 (5), p.755-758

1999

Volltextzugriff (PDF)

3-pyridylethanolamines : Potent and selective human β3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 1998-11, Vol.8 (21), p.3087-3092

1998

Volltextzugriff (PDF)

Human β 3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties

Bioorganic & medicinal chemistry letters, 2001-02, Vol.11 (3), p.379-382

2001

Volltextzugriff (PDF)

Discovery of a Potent, Orally Bioavailable β 3 Adrenergic Receptor Agonist, ( R )- N -[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3832-3836

2000

Volltextzugriff (PDF)

Potent, selective 3-pyridylethanolamine β3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (17), p.1971-1973

2000

Volltextzugriff (PDF)

Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β 3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2000, Vol.10 (20), p.2283-2286

2000

Volltextzugriff (PDF)

Desensitization of β3-adrenergic receptor- stimulated adenylyl cyclase activity and lipolysis in rats

Life sciences (1973), 1998-01, Vol.62 (7), p.627-638

1998

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)
Buchkapitel
(1)

Sprache

Englisch
(51)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(32)
Medical Sciences
(25)
Pharmacology. Drug Treatments
(24)
Science & Technology
(22)
Animals
(20)
Humans
(20)
Life Sciences & Biomedicine
(18)
Cricetinae
(12)
Mice
(12)
Receptors, Glucagon - Antagonists & Inhibitors
(12)
Pharmacology & Pharmacy
(11)
General And Cellular Metabolism. Vitamins
(10)
Catecholaminergic System
(9)
Chemistry
(9)
Chemistry, Medicinal
(9)
Glucagon
(9)
Neuropharmacology
(9)
Neurotransmitters. Neurotransmission. Receptors
(9)
Chemistry, Organic
(8)
Mice, Transgenic
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of potent, orally active benzimidazole glucagon receptor antagonists

Discovery of a Novel Glucagon Receptor Antagonist N-[(4-{(1S)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes

Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

Potent, selective human β3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore

Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression

Human β3-Adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents

Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists

Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonist

Human β3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties

Human β 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Molecular approaches to the discovery of new treatments for obesity

3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic properties

Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptor

Mutational analysis of beta-adrenergic receptor glycosylation

L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability

Human β3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

3-pyridylethanolamines : Potent and selective human β3 adrenergic receptor agonists

Human β 3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties

Discovery of a Potent, Orally Bioavailable β 3 Adrenergic Receptor Agonist, ( R )- N -[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Potent, selective 3-pyridylethanolamine β3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore

Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β 3 adrenergic receptor agonists

Desensitization of β3-adrenergic receptor- stimulated adenylyl cyclase activity and lipolysis in rats

Suchergebnisse filtern